To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs.
Summary
HR3419 is an early-stage bill reauthorizing telehealth grant programs that has passed the House but stalled in the Senate with no appropriation attached. There is zero guaranteed funding and no direct market impact until an appropriations bill funds these grants.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR3419 authorizes $42.05M/year for telehealth grants through FY2030 but appropriates zero dollars — no funding is guaranteed.
- 2.The bill is stuck in the Senate after House passage; limited cosponsor support (1 cosponsor) suggests low momentum.
- 3.No direct market impact exists until an appropriations bill funds these grants — no tickers to trade on.
Market Implications
No market implications at this stage. The bill is purely procedural with no funded mechanism. Investors should monitor whether an appropriations bill attaches funding — only then would telehealth platform vendors like Teladoc Health ($TDOC) or Amwell ($AMWL) potentially benefit from grant-funded network deployments in rural areas. Current status: zero actionable signal.
Full Analysis
HR3419, introduced by Rep. Valadao (R-CA) in May 2025, amends Section 330I(q) of the Public Health Service Act to reauthorize telehealth network and telehealth resource centers grant programs through FY2030 at $42.05 million per year. The bill passed the House unanimously (48-0 committee vote) and was reported with H. Rept. 119-322 in October 2025. However, it currently sits in the Senate after committee referral on April 22, 2026, with no further action. This is an authorization bill only — it sets a spending ceiling but does not appropriate actual money. The $42.05 million per year figure is the authorized maximum; actual disbursement requires a separate appropriations bill. Without that, the grant programs remain unfunded. The bill's sponsor is a junior House member, and there is only one cosponsor, indicating limited legislative momentum. The market impact is currently zero — no actionable tickers can be identified because there is no guaranteed revenue stream for any company. If funded, the grants would flow to healthcare providers and telehealth network operators in rural and underserved areas, potentially benefiting telehealth platform vendors and rural hospital operators, but that scenario requires Congress to pass an appropriations bill, which is uncertain at this stage. The legislative timeline is stalled: the bill must pass the Senate, be signed into law, and then receive appropriated funds — none of which is imminent.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND): $1.8B Department of State Federal Award
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →